PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Between solstices and equinoxes

Reducing stigma around bipolar disorder on stage. New paper in JCOM

2025-11-10
(Press-News.org) “People tend to joke about mood swings, saying ‘my mood swings throughout the day, I’m already a bit bipolar,’ or joke with each other saying ‘everything is bipolar.’ And it’s not quite like that, as bipolar disorder has a biological component.”

This is one of the statements featured in a short trailer on YouTube about bipolar disorder. The video is connected to the play Oxímoro, entre Solstícios e Equinócios (Oxymoron, Between Solstices and Equinoxes) by Marionet, a Portuguese theatre company that brings scientific research topics to the stage.

The play was developed through an in-depth collaboration with doctors, researchers, and patients, with the goal of informing and raising public awareness about bipolar disorder, helping to reduce the stigma surrounding this and other mental health conditions.

The project also included an analysis of audience responses to the performance, with a specific focus on emotional engagement. The results of this experience are described in a practice insight  published in the special issue of emotions and science communication in Journal of Science Communication (JCOM). According to the authors, the audience’s emotional response—empathy, emotional resonance, and personal identification—helped facilitate the assimilation of scientific information and contributed to reducing the stigma surrounding mental illness.

 

The Marionet theatre company has extensive experience staging works inspired by scientific research, explains Mário Montenegro (Marionet and Centre for Interdisciplinary Studies, University of Coimbra). “We have been working with science for 25 years,” he says. “But we only started to work on health subjects a few years ago.”

The company collaborates with scientific partners such as the Center for Neuroscience and Cell Biology at the Universidade de Coimbra, which also conducts research on mental health. For this play, Montenegro and his colleagues collaborated with a group from the center with a project focused specifically on bipolar disorder, as well as health practitioners from the Integrated Psychiatry Responsibility Center of the Coimbra Hospital and University Center.

The scientific component entered the project from the very beginning, during the writing phase, and was complemented by direct testimonies from patients. “We felt the need to change our creative process, because these were delicate subjects that touched people’s lives. We realized we needed to be even better informed,” explains Montenegro. “So we based our work on interviews with patients, doctors, nurses, and relatives—to hear, in their own words, their experiences with these conditions. From those interviews, we then began building our creative material.”

Based on these interviews, Montenegro and his colleagues wrote the script for the play, composed of several scenes featuring different characters and situations, rather than a single story with a defined set of protagonists. The play, performed by professional actors, ran for five days at the BlackBox of Convento São Francisco in Coimbra, Portugal, from March 20 to 24, 2024, with a total of six performances.

After each show, audience members were invited to complete a questionnaire about their experience. Of the approximately 300 attendees overall, 54 responded. “It was an emotionally very strong play,” says Montenegro. “And the emotional engagement from the audience was very strong as well.” According to the authors’ analysis of the questionnaires, emotions proved to be a key factor in helping audiences understand and remember information about bipolar disorder. Engagement, empathy, and personal identification helped assimilate scientific content and contributed to reducing stigma and stereotypes, humanizing the illness.

Emotion, therefore, does not interfere with message accuracy, Montenegro believes: when intentionally and thoughtfully guided through staging and language, it strengthens it, motivating audiences to learn more and leaving a deeper, longer-lasting impact than purely informational communication. As he puts it: “An important aspect of our play was not to offer the audience a pre-established interpretation of the illness or of the situations represented in each scene. We left the interpretation open so that spectators could form their own opinions. In this way, everyone could receive the content in their own way and react emotionally according to their own sensitivity—because we are all very different.”

The paper “Theatre and bipolar disorder: dealing with emotions” by Mário Montenegro, Silvia Carballo and Francisca Moreira is part of a JCOM special issue titled “Emotions and Science Communication”.

“Theather is indeed a very powerful way for engaging people in science and health issues; recently, very important initiatives have been developed worldwide, including this (very beautiful) one from Portugal”, says Luisa Massarani, researcher at the Brazilian Institute of Public Communication of Science and Technology and one of the guest editors of the special issue on emotions and science communication.

"Despite their significant role, emotions are under-theorised and under-researched in science communication - although there is a growing interest among researchers and practitioners in understanding their role in science communication. This led us - Neta Shaby (UK), Daniel Silva Luna and myself - to propose this special issue, inviting researchers and practitioners around the globe to submit their manuscripts. We hope this special issue inspires other people to think further about the different facets of emotions and science communication , as well as to carry out more studies on the subject,” she says.


 

END


ELSE PRESS RELEASES FROM THIS DATE:

New study gives people with eczema freedom to choose how often to bathe

2025-11-10
A major study has found that people with eczema are able to bathe either daily or weekly, without any impact to their symptoms. The findings of the new study, which are published in the British Journal of Dermatology, are great news for people living with eczema, as it will mean they will have the freedom to choose how often to bathe without fear it will worsen their symptoms. People with eczema often have questions about how best to bathe including how often to have a bath or shower. The ‘Eczema Bathing study’, was prioritised and developed by people living with eczema, in partnership with researchers from ...

Children’s dental health still very poor despite interventions 

2025-11-10
Children's access to NHS dentists and rates of tooth decay remain very poor despite improvements from national government interventions, oral health experts say.  Analysis of the latest government data by the Child of the North initiative gives cause for cautious optimism, they say, but the schemes need to be scaled up and strengthened to meet the needs of young people across the country.  The latest update, titled Improving Children’s Oral Health Update: Integrated Health and Education Solutions, is the seventh to be released ...

Hospital patients who feel short of breath are six times more likely to die

2025-11-10
The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published today (Monday) in ERJ Open Research [1]. Patients who were in pain were not more likely to die.   The study of nearly 10,000 people suggests that asking patients if they are feeling short of breath could help doctors and nurses to focus care on those who need it most.   The study is the first of its kind and was led by Associate Professor Robert Banzett from Beth Israel Deaconess Medical Center, Harvard Medical School, ...

Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children

2025-11-10
Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with autism or ADHD in children, finds an in-depth evidence review published by The BMJ today, in direct response to recent announcements around the safety of using paracetamol in pregnancy. The researchers say confidence in the findings of existing evidence reviews and studies on this topic is low to critically low, and suggest that any apparent effect seen in previous studies may be driven by shared genetic and environmental factors within families. Regulatory bodies, clinicians, pregnant women, parents, and those affected by autism and ADHD should be informed ...

Should kids be screened for high cholesterol genes?

2025-11-09
Nov. 9, 2025--In the United States, one in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels from birth.   If high cholesterol isn’t lowered early, people with this genetic condition, called familial hypercholesterolemia (FH), have a high risk of having a heart attack or stroke as early as their 30s or 40s. But only about 1 in 10 of people living with FH (1.5 million Americans) is aware of their condition.  A new modeling study conducted by researchers at Columbia and Harvard Universities finds ...

Weight loss drugs don’t increase the risk of pancreatitis or adverse cardiac events in patients with high triglycerides

2025-11-09
In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events. Since the first GLP-1 receptor agonists (GLP1RAs), more commonly known now as weight loss drugs, were approved in 2005, some clinicians have been hesitant to prescribe them to people who have very high triglycerides. That’s because these patients are typically at high risk of pancreatitis, and the drugs interact with the pancreas.  In the new study, Intermountain researchers found that ...

Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function

2025-11-09
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors with preserved cardiac function enrolled in five global clinical trials. The study concludes that beta-blockers offer no clinical benefit for this patient group, which today represents the majority of infarction survivors. The study was made possible by close collaboration between CNIC researchers and the ...

Targeted vitamin D3 supplementation cuts risk of heart attack patients having a second heart attack in half, new intermountain health study finds

2025-11-09
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City finds. In a large, randomized clinical trial, Intermountain Health researchers have found that treating heart attack patients in a “target to treat” fashion, where patients’ blood levels of vitamin D were monitored and vitamin D3 dosing adjusted to achieve optimal levels, cut their risk of a second heart attack in half. Results of the study were presented on Nov. 9 at the 2025 American Heart Association Scientific ...

Any form of hypertension during pregnancy significantly increases postpartum cardiovascular risk including death, new study finds

2025-11-09
A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications — including heart attack, stroke, heart failure, and death — within five years of giving birth. The study found that women who experienced HDP during pregnancy were significantly more likely to develop serious cardiovascular-related issues compared to those without HDP. These findings underscore the growing body of evidence over the past two decades linking pregnancy-related hypertension to ...

Opening all blocked arteries with stents reduces risk of death from cardiovascular causes compared with opening only the culprit artery in heart attack patients

2025-11-09
Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only culprit artery causing the heart attack according to a new, large international study led by researchers at the Population Health Research Institute (PHRI), a joint organization of McMaster University and Hamilton Health Sciences. The results were published simultaneously in The Lancet and presented in a Late-Breaking Clinical Science Featured Research ...

LAST 30 PRESS RELEASES:

Seeing the unseen: Scientists demonstrate dual-mode color generation from invisible light

Revealing deformation mechanisms of the mineral antigorite in subduction zones

I’m walking here! A new model maps foot traffic in New York City

AI model can read and diagnose a brain MRI in seconds

Researchers boost perovskite solar cell performance via interface engineering

‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasize

James Webb Space Telescope reveals an exceptional richness of organic molecules in one of the most infrared luminous galaxies in the local Universe

The internet names a new deep-sea species, Senckenberg researchers select a scientific name from over 8,000 suggestions.

UT San Antonio-led research team discovers compound in 500-million-year-old fossils, shedding new light on Earth’s carbon cycle

Maternal perinatal depression may increase the risk of autistic-related traits in girls

Study: Blocking a key protein may create novel form of stress in cancer cells and re-sensitize chemo-resistant tumors

HRT via skin is best treatment for low bone density in women whose periods have stopped due to anorexia or exercise, says study

Insilico Medicine showcases at WHX 2026: Connecting the Middle East with global partners to accelerate translational research

From rice fields to fresh air: Transforming agricultural waste into a shield against indoor pollution

University of Houston study offers potential new targets to identify, remediate dyslexia

Scientists uncover hidden role of microalgae in spreading antibiotic resistance in waterways

Turning orange waste into powerful water-cleaning material

Papadelis to lead new pediatric brain research center

Power of tiny molecular 'flycatcher' surprises through disorder

Before crisis strikes — smartwatch tracks triggers for opioid misuse

Statins do not cause the majority of side effects listed in package leaflets

UC Riverside doctoral student awarded prestigious DOE fellowship

UMD team finds E. coli, other pathogens in Potomac River after sewage spill

New vaccine platform promotes rare protective B cells

Apes share human ability to imagine

Major step toward a quantum-secure internet demonstrated over city-scale distance

Increasing toxicity trends impede progress in global pesticide reduction commitments

Methane jump wasn’t just emissions — the atmosphere (temporarily) stopped breaking it down

Flexible governance for biological data is needed to reduce AI’s biosecurity risks

Increasing pesticide toxicity threatens UN goal of global biodiversity protection by 2030

[Press-News.org] Between solstices and equinoxes
Reducing stigma around bipolar disorder on stage. New paper in JCOM